Cannabis Stocks Declined -9.9% in May; Now -43.7% YTD
The largest Canadian Licensed Producers (LP), as tracked in the Canadian Pure-play LP Pot Stock Index, is down by 15.6% in May. [more]
The largest Canadian Licensed Producers (LP), as tracked in the Canadian Pure-play LP Pot Stock Index, is down by 15.6% in May. [more]
This past quarter, Canadian cannabis companies focused on consolidating operations, adjusting asset valuations, and launching Cannabis 2.0 derivative products. While in the U.S., cannabis companies increased production capacity and scaled retail stores in order to be ready when federal legalization of cannabis becomes a reality. [more]
Since Canada approved the sale of cannabis derivatives late last year, the high-margin cannabis beverage market quickly grew with the introduction of new products and brands, and an increase in M&A, financings, and other deals. [more]
At current pace of operation & CAPEX spending, Aurora and Curaleaf have less than two quarters of runway left while iAnthus defaults on debt payment and MedMen needs $250M to execute turnaround plan. [more]
Aurora lays off 500 employees and writes down $1B; Hexo dismisses 200 employees and writes down $270M; Canopy closes two facilities with 500 employees and stops plans for third facility; many U.S. listed cannabis companies fall under $1/share; Canopy closes all retail stores. [more]
Canopy’s stock price has dropped 51% in the past year but as it progresses towards profitability, its stock price has started an upward trend with a 14% increase year-to-date. [more]
Horizons Marijuana Life Sciences ETF (TSX: HMMJ), the first established cannabis ETF, has fallen almost 60% in share price in the past year and Evolve Funds Group announced it will be shutting down of two of its cannabis focused ETFs [more]
Cannabis companies saw their stock prices fall quarter after quarter as the top nine cannabis companies are currently on average half the value of what they were one year ago. [more]
Country after country are criticizing the e-cigarette regarding health concerns and increasing prevalence of vaping activities in minors. [more]
Canopy (NYSE: CGC; TSX: WEED) announced that it has received an extraction license from Health Canada for its KeyLeaf Life Sciences facility in Saskatchewan, which is expected to have an extraction capacity of 5,000 kilograms (kg) per day. [more]
Copyright © 2024 | MH Magazine WordPress Theme by MH Themes